Drug intelligence / Profile preview

Stemsap-A

Development stage
Unknown
Lead developer
SAP
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intradermal
01

Overview

Stemsap-A is an extracellular vesicle-rich conditioned medium derived from human adipose-derived mesenchymal stem cells (AD-MSCs). Developed by the Japanese company S-AP, it is being investigated as a regenerative therapy for androgenetic alopecia (AGA). The product contains a concentrated secretome of growth factors, cytokines, and exosomes secreted by stem cells during the culture process. These bioactive components are thought to stimulate hair follicle regeneration, promote the transition of hair follicles from the telogen (resting) phase to the anagen (growth) phase, and improve the microenvironment of the scalp. Stemsap-A is administered via intradermal injections into the scalp, providing a cell-free alternative to direct stem cell transplantation while leveraging the paracrine signaling benefits of MSCs.

Brand names
Stemsap-A
Other names
Adipose-derived mesenchymal stem cell conditioned mediumAD-MSC-CMExtracellular vesicle-rich conditioned medium
02

Targets

DKK2 (Dickkopf-related protein 2)LRP5 (Low-density lipoprotein receptor-related protein 5)VEGFR-1 (Vascular endothelial growth factor receptor 1)FZD (Frizzled receptor)

Beyond the preview

Go deeper on Stemsap-A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stemsap-A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call